Skip to main content
Saturday
August 15, 2026
Sign In
Subscribe
Latest
Economy
Banking
Stocks
Industry
Analysis
Bazaar
RMG
Corporates
Aviation
Videos
TBS Today
TBS Stories
TBS World
News of the day
TBS Programs
Podcast
Editor's Pick
World+Biz
Features
Panorama
The Big Picture
Pursuit
Habitat
Thoughts
Tales from the Edge
Splash
Mode
Tech
Explorer
Brands
In Focus
Book Review
Earth
Food
Luxury
Wheels
Subscribe
Get the Paper
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Bangladesh
Supplement
Infograph
Explainer
Archive
Gallery
Long Read
Interviews
Offbeat
Magazine
Climate Change
Health
Cartoons
বাংলা
SATURDAY,
AUGUST 15, 2026
Johnson & Johnson
Johnson & Johnson
Trump suggests Pfizer could win US Covid-19 vaccine approval, JNJ to come later
Trump also cited efforts by Moderna Inc and AstraZeneca Plc
Johnson & Johnson to test coronavirus vaccine in 60,000 volunteers
Johnson & Johnson to buy Momenta for about $6.5 billion
Britain lines up more potential Covid-19 vaccine supplies with J&J, Novavax deals
EU reserves 400 mln doses of potential J&J virus vaccine
US signs $1 billion vaccine deal with Johnson & Johnson
J&J starts human safety trial for its Covid-19 vaccine candidate
EU talks with Pfizer, Sanofi, J&J on Covid vaccines hit snags - sources
J&J says in talks with Japan, Gates Foundation to lock in deals on Covid-19 vaccine
Johnson & Johnson profit tumbles 35% as Covid-19 slams medical device sales
Nonprofits urge Johnson & Johnson to halt sales of Baby Powder globally
Catalent plant in Italy will help produce J&J's potential Covid-19 vaccine
Johnson & Johnson drops skin whitening creams
Show More